Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8CYC

SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34

Summary for 8CYC
Entry DOI10.2210/pdb8cyc/pdb
EMDB information27074
DescriptorSpike glycoprotein, pan-sarbecovirus nanobody 2-34 (2 entities in total)
Functional Keywordssars-cov-2, spike protein, nanobody, broad binding, viral protein
Biological sourceSevere acute respiratory syndrome coronavirus 2
More
Total number of polymer chains6
Total formula weight466007.51
Authors
Huang, W.,Taylor, D. (deposition date: 2022-05-23, release date: 2022-07-06, Last modification date: 2024-11-13)
Primary citationXiang, Y.,Huang, W.,Liu, H.,Sang, Z.,Nambulli, S.,Tubiana, J.,Williams Jr., K.L.,Duprex, W.P.,Schneidman-Duhovny, D.,Wilson, I.A.,Taylor, D.J.,Shi, Y.
Superimmunity by pan-sarbecovirus nanobodies.
Cell Rep, 39:111004-111004, 2022
Cited by
PubMed Abstract: Vaccine boosters and infection can facilitate the development of SARS-CoV-2 antibodies with improved potency and breadth. Here, we observe superimmunity in a camelid extensively immunized with the SARS-CoV-2 receptor-binding domain (RBD). We rapidly isolate a large repertoire of specific ultra-high-affinity nanobodies that bind strongly to all known sarbecovirus clades using integrative proteomics. These pan-sarbecovirus nanobodies (psNbs) are highly effective against SARS-CoV and SARS-CoV-2 variants, including Omicron, with the best median neutralization potency at single-digit nanograms per milliliter. A highly potent, inhalable, and bispecific psNb (PiN-31) is also developed. Structural determinations of 13 psNbs with the SARS-CoV-2 spike or RBD reveal five epitope classes, providing insights into the mechanisms and evolution of their broad activities. The highly evolved psNbs target small, flat, and flexible epitopes that contain over 75% of conserved RBD surface residues. Their potencies are strongly and negatively correlated with the distance of the epitopes from the receptor binding sites.
PubMed: 35738279
DOI: 10.1016/j.celrep.2022.111004
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.9 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon